Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM SHS
-
Total 13F shares
-
319,143
-
Share change
-
+19,042
-
Total reported value
-
$1,598,917
-
Price per share
-
$5.01
-
Number of holders
-
25
-
Value change
-
+$95,391
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of Serina Therapeutics, Inc. - COM SHS (SER) as of Q4 2024
As of 31 Dec 2024,
Serina Therapeutics, Inc. - COM SHS (SER) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
319,143 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, Waverly Advisors, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HighTower Advisors, LLC, Keel Point, LLC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, UBS Group AG, and BlackRock, Inc..
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.